ABG vs BABA

ABG exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust accounting strength, though the absence of an Altman Z-Score limits distress risk assessment. The stock appears undervalued relative to its Graham Number of $349.14 and intrinsic value of $801.22, trading at $238.04, but elevated leverage and weak technicals weigh on sentiment. Solid profitability metrics, double-digit revenue and earnings growth, and strong ROE contrast with insider selling and a bearish technical trend. Analysts concur with a 'hold' rating, aligning with mixed signals between value and sentiment.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.